Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Launch of New Research Project to Investigate Acetaminophen-Induced Liver Damage

Share Article

The launch of the project comes as scores of Tylenol lawsuit plaintiffs seek compensation for serious and life-threatening liver injures allegedly caused by the acetaminophen in Tylenol-brand medications.

Free Case Review
The fact that scores of people are currently pursuing Tylenol lawsuits for liver injuries allegedly caused by the acetaminophen in those products would suggest that this type of additional research is urgently needed.

As scores of Tylenol lawsuits (http://www.tylenollawsuitcenter.com/ ) involving liver damage allegations continue to move through federal court, Bernstein Liebhard LLP notes that a group of professors at Indiana University have launched a new research project to develop a model of acetaminophen-induced liver injuries. According to a report from the Associated Press, the project will focus on acetaminophen due to its popularity among U.S. consumers. The active ingredient in Tylenol products and dozens of other over-the-counter drugs, acetaminophen is the leading cause of liver injuries in the U.S.*

“Federal health regulators have repeatedly warned about the potential for acetaminophen to cause serious liver damage. The fact that scores of people are currently pursuing Tylenol lawsuits for liver injuries allegedly caused by the acetaminophen in those products would suggest that this type of additional research is urgently needed,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is offering free legal reviews to consumers who were allegedly harmed by a Tylenol-brand over-the-counter medication.

Tylenol Liver Damage Litigation
Recently, an investigation conducted by Consumer Reports found that acetaminophen-induced liver damage sends more than 80,000 people to the emergency room every year. Among other things, the report detailed one study which suggested that exceeding just 4,000 milligrams of acetaminophen for just a few days can result in serious liver problems and other complications. Yet the daily limits recommended for many over-the-counter acetaminophen products come very close to this threshold.**

In January, the U.S. Food & Drug Administration (FDA) did finalize new guidance for the use of acetaminophen in prescription medications. However, these new guidelines do not apply to over-the-counter medications like Tylenol.*** And in October the agency issued draft guidance regarding over-the-counter liquid pediatric medications that contain acetaminophen. ****

According to court documents, at least 163 Tylenol liver damage claims are currently pending in a federal multidistrict litigation underway in the U.S. District Court, Eastern District of Pennsylvania. All of the complaints allege that Johnson & Johnson and McNeil Consumer Healthcare failed to provide consumers with adequate warnings regarding the risks associated with acetaminophen contained in Tylenol-brand medications. In many cases, plaintiffs claim that liver damage caused by Tylenol occurred even though the medication was used in accordance with label directions, and was severe enough to result in hospitalization, liver transplantation, or death. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)

Individual who experienced acetaminophen-induced liver damage allegedly related to their use of a Tylenol-brand medication may be entitled to join this litigation. To learn more about filing a Tylenol lawsuit, please visit Bernstein Liebhard LLP’s website. Free, confidential and no-obligation case reviews are available by calling 800-511-5092.

*washingtontimes.com/news/2014/dec/4/iu-research-into-liver-toxicology-wins-21m-grant/, Associated Press, December 4, 2014
**federalregister.gov/articles/2011/01/14/2011-709/prescription-drug-products-containing-acetaminophen-actions-to-reduce-liver-injury-from, Federal Register, January 2014
***fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM417568.pdf, FDA, October 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website